(Q44013589)

28 November 2017

title

TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer (English)

1 reference

28 November 2017

1 reference

1 reference

Zuo-Ming Zhang

1

1 reference

28 November 2017

Yibaina Wang

2

1 reference

28 November 2017

Rong Huang

3

1 reference

28 November 2017

Yu-Peng Liu

4

1 reference

28 November 2017

Xia Li

5

1 reference

28 November 2017

Fu-Lan Hu

6

1 reference

28 November 2017

Lin Zhu

7

1 reference

28 November 2017

Fan Wang

8

1 reference

28 November 2017

Bin-Bin Cui

9

1 reference

28 November 2017

Xin-Shu Dong

10

1 reference

28 November 2017

Ya-Shuang Zhao

11

1 reference

28 November 2017

publication date

6 July 2014

1 reference

Journal of Cancer Research and Clinical Oncology

28 November 2017

published in

1 reference

28 November 2017

volume

140

1 reference

28 November 2017

issue

12

1 reference

28 November 2017

page(s)

2119-2127

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-014-1766-4

28 November 2017

exact match

0 references

cites work

Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Methylation-induced repression--belts, braces, and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Identification of novel epigenetic markers for clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

TFAP2E-DKK4 and chemoresistance in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

The AP-2 family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Estimates of the cancer incidence and mortality in Europe in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Dependence of chemotherapy response on p53 mutation status in a panel of human cancer lines maintained in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Determining the effect of DNA methylation on gene expression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Recent patents and advances in genomic biomarker discovery for colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

DNA methylation: an alternative pathway to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Reduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Methylation-sensitive high-resolution melting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1766-4

Chromosomal instability, aneuploidy, and gene mutations in human sporadic colorectal adenomas.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24996990

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24996990

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24996990

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00432-014-1766-4

1 reference

28 November 2017

1 reference